Literature DB >> 1523531

Prognostic factors in cervical human papillomavirus infections.

V Kataja1, S Syrjänen, R Mäntyjärvi, M Yliskoski, S Saarikoski, K Syrjänen.   

Abstract

A prospective follow-up study, without further treatment, of a series of 528 women with cervical human papillomavirus (HPV) infections was conducted from 1981 to the present, with a mean follow-up time of 60.3 months (standard deviation 25.1 months). The women visited the Outpatient Department of Gynecology, Kuopio University Hospital, Kuopio, Finland at six-month intervals. At each visit, a thorough gynecologic examination, PAP-smear, and colposcopy with or without punch biopsy were performed. Epidemiologic data were collected by questionnaire, and complete follow-up data were available for 480 of the 528 women. Of these 480 cases of HPV infection, 58.3% regressed spontaneously, and clinical progression was detected in 14.8%. To establish the prognostic factors associated with the clinical course of cervical HPV infections, the Cox proportional hazards regression model was applied. In the analysis, five variables were included: age, PAP-smear class, grade of cervical intraepithelial neoplasia (CIN), HPV type, and colposcopic appearance at the first visit. In general, patient age at the time of diagnosis was inversely related to the probability of spontaneous regression (P less than 0.01). CIN II, CIN III and HPV type 16 were the most significant independent prognostic factors for progression of cervical HPV infections (P less than 0.001, P less than 0.0001, and P less than 0.001, respectively). We conclude that whenever HPV 16 DNA is found in the cervical biopsy with any grade of CIN, the lesion should be treated. Similarly, the presence of CIN II and CIN III indicates treatment whether HPV DNA are detected or not.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1523531     DOI: 10.1097/00007435-199205000-00009

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  11 in total

Review 1.  Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

Review 2.  [Precancerous lesions of the uterine cervix: morphology and molecular pathology].

Authors:  L-C Horn; K Klostermann
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

3.  Papillomavirus-associated balanoposthitis.

Authors:  A Wikström; G von Krogh; M A Hedblad; S Syrjänen
Journal:  Genitourin Med       Date:  1994-06

4.  Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses.

Authors:  Tae Jeong Oh; Chang Jin Kim; Suk Kyung Woo; Tae Seung Kim; Dong Jun Jeong; Myung Soon Kim; Sunwoo Lee; Hyun Sill Cho; Sungwhan An
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.

Authors:  P Zazove; B D Reed; L Gregoire; A Ferenczy; D W Gorenflo; W D Lancaster
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

6.  Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes.

Authors:  M V Jacobs; A M de Roda Husman; A J van den Brule; P J Snijders; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

7.  Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.

Authors:  J M Walboomers; A M de Roda Husman; P J Snijders; H V Stel; E K Risse; T J Helmerhorst; F J Voorhorst; C J Meijer
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

8.  Immunotherapy of gynaecological high-risk human papilloma virus infection with human leukocyte ultrafiltrate.

Authors:  H Spitzbart; U B Hoyme
Journal:  Infect Dis Obstet Gynecol       Date:  2000

9.  Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype.

Authors:  S Hietanen; K Syrjänen; S Syrjänen
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

10.  The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis.

Authors:  Jinyun Li; Chongchang Zhou; Haojie Zhou; Tianlian Bao; Tengjiao Gao; Xiangling Jiang; Meng Ye
Journal:  Ther Clin Risk Manag       Date:  2016-08-18       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.